Affordable Access

Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptic muscarinic antagonist secoverine in mice.

Authors
Type
Published Article
Journal
Behavioural Brain Research
0166-4328
Publisher
Elsevier
Publication Date
Volume
47
Issue
1
Pages
93–95
Identifiers
PMID: 1571105
Source
Medline
License
Unknown

Abstract

Post-trial administration of secoverine (0.5, 1 and 2.5 mg/kg), a presynaptic muscarinic blocker, improved retention in mice tested in a passive avoidance task. The nootropic drug oxiracetam (50 mg/kg), given before both acquisition and retention trial, had no effect alone, but significantly enhanced secoverine improving effects. Performance improvements were also found in combining ineffective doses of the two compounds. Even if not necessarily through a direct and specific action, oxiracetam might activate cholinergic function. Thus, performance improvements resulting from the combination of oxiracetam and secoverine may be due to a simultaneous activation of different cholinergic mechanisms.

Statistics

Seen <100 times